Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which chemotherapy regimen is more effective in
treating non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare two different docetaxel regimens in treating
patients who have stage IIIB or stage IV non-small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Istituto Nazionale per lo Studio e la Cura dei Tumori